1. Chen, Jiming, Shan, Wulin, Jia, Qiucheng, Wang, Zengying, Xia, Bairong. 2024. USP33 facilitates the ovarian cancer progression via deubiquitinating and stabilizing CBX2. In Oncogene, 43, 3170-3183. doi:10.1038/s41388-024-03151-9. https://pubmed.ncbi.nlm.nih.gov/39256572/
2. Liu, Xinyuan, Xu, Jian, Shen, Bingbing, Xu, Jichuan, Jiang, Jianxin. 2023. USP33 promotes pancreatic cancer malignant phenotype through the regulation of TGFBR2/TGFβ signaling pathway. In Cell death & disease, 14, 362. doi:10.1038/s41419-023-05871-4. https://pubmed.ncbi.nlm.nih.gov/37322017/
3. Ke, Xianfu, Hu, Huiying, Peng, Qianyu, Ying, Huazhong, Chu, Xiaofeng. 2023. USP33 promotes nonalcoholic fatty acid disease-associated fibrosis in gerbils via the c-myc signaling. In Biochemical and biophysical research communications, 669, 68-76. doi:10.1016/j.bbrc.2023.05.100. https://pubmed.ncbi.nlm.nih.gov/37267862/
4. Mishra, Ritu, Banerjea, Akhil C. 2021. SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia. In Frontiers in immunology, 12, 656700. doi:10.3389/fimmu.2021.656700. https://pubmed.ncbi.nlm.nih.gov/33936086/
智鼠故事 
